SVRA | SavaraNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$4.73
-$0.09 (-1.87%)

Savara (SVRA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
below both $4.73 vs 50 $5.06 / 200 $5.39
Projection
No cross projected
Test
No active test
Last cross
Death cross 11 Sep 2026 ยท projected 3 bars out ยท tested 4 bars

Weekly as of 30 Oct 16:00 ET

Price
between the two $4.82 vs 50 $5.47 / 200 $3.95
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 24 Apr 2023 ยท projected 2 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $4.75 vs 50 $4.78 / 200 $5.36
Projection
No cross projected
Test
No active test
Last cross
Death cross 15 Sep 2026 bar 2 ยท projected 20 bars out ยท tested 5 bars

Cross history

33
crosses on record since 2018
16 golden17 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
15 Sep 2026Death4-hour20 bars out5 bar cross test
11 Sep 2026Death flatdaily3 bars out4 bar cross test
30 Jun 2026Golden4-hour29 bars outNot tested
24 Mar 2026Death4-hour27 bars outNot tested
12 Sep 2025Golden steepdaily29 bars outNot tested

About SVRA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$8.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.